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SUMMARY 
The risk of cardiovascular disease is dramatically increasing in Africans (black). The 
prothrombotic stress response contributes to atherothrombotic disease and is modulated by 
depressive symptom. We examined coagulation reactivity to acute mental stress and its 
relation to psychological well-being in Africans relative to Caucasians (white). 102 African 
and 165 Caucasian school teachers underwent the Stroop Color-Word Conflict test. 
Circulating levels of von Willebrand factor (VWF) antigen, fibrinogen, and D-dimer were 
measured before and after the Stroop. Cardiovascular reactivity measures were also obtained. 
All participants completed the Patient Health Questionnaire-9 and the General Health 
Questionnaire-28 for the assessment of depressive symptoms and total psychological distress, 
respectively. After controlling for covariates, resting levels of VWF, fibrinogen, and D-dimer 
were higher in Africans than in Caucasians (all p-values ≤0.006). Depressive symptoms and 
psychological distress were not significantly associated with resting coagulation measures. 
Stress reactivity in VWF (p<0.001) and fibrinogen (p=0.016), but not in D-dimer (p=0.27), 
were decreased in Africans relative to Caucasians with Africans showing greater reactivity of 
total peripheral resistance (p=0.017). Depressive symptoms, but not general psychological 
distress, were associated with greater VWF increase (p=0.029) and greater fibrinogen 
decrease (p=0.030) in Africans relative to Caucasians. In conclusion, Africans showed greater 
hypercoagulability at rest but diminished procoagulant reactivity to acute mental stress when 
compared with Caucasians. Ethnic differences in the vascular adrenergic stress response 
might partially explain this finding. Depressive symptoms were associated with exaggerated 
VWF reactivity in Africans relative to Caucasians. The clinical implications of these findings 
for Africans need further study. 
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INTRODUCTION 
Enhanced coagulation, impaired fibrinolysis, endothelial activation, and hyperactive 
platelets play an important role in the development of atherogenesis, atherothrombosis, and 
acute coronary syndromes (ACS) (1). During acute mental stress, healthy individuals show a 
prothrombotic state that is viewed as an adaptive fight-flight response protecting the organism 
from excessive bleeding should injury occur (2, 3; for review). Fibrinogen, von Willebrand 
factor antigen (VWF:Ag) and D-Dimer, the latter indicating fibrin turnover, are particularly 
responsive to acute mental stress (4, 5). Excessive stress procoagulant changes might 
potentially increase the risk of incident cardiovascular disease (CVD) and recurrent CVD 
events (3). For instance, stress-induced fibrinogen increase was associated with carotid artery 
stiffness (6) and predicted an increase in ambulatory systolic blood pressure (SBP) over three 
years in healthy individuals (7). Owing to impaired endothelial anticoagulant function, 
patients with atherothrombotic diseases showed greater platelet activation (8) and D-dimer 
increase (9) than controls free of CVD. Moreover, patients with emotional triggers like 
depressive feelings in the two hours before ACS onset, showed greater platelet aggregation 
during laboratory mental stress than patients reporting non-emotional triggers (10). 
Depressive symptoms have also been associated with stress-induced elevation in platelet 
reactivity (11) and D-dimer (12) in elderly subjects, thereby supporting the notion that 
hypercoagulability is one mechanism linking depression with an increased CVD risk (13). 
Potential ethnical differences in the acute procoagulant response to stress and their 
relation to depressive symptoms have not previously been explored. Such biobehavioral 
research seems important for urbanized Africans in whom a concerning increase in CVD can 
be observed, much of it being a consequence of their transition from a traditional African to a 
modernized “Western” lifestyle (14). For instance, in Africans, the CVD risk predicted by 
fibrinogen becomes stronger with an increasing degree of urbanization (15). Moreover, 
subclinical atherosclerosis, as measured by increased carotid intima media thickness (CIMT), 
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was greater in Africans than in Caucasians (16) as well as in those with more severe 
depressive symptoms of both these ethnicities (17). 
The autonomic nervous system and hypothalamic pituitary adrenal axis are the two 
major physiologic stress response systems in humans. As cortisol peaks between 15 and 30 
minutes after stress onset, prothrombotic changes within a few minutes of acute stress are 
largely governed by the sympathetic nervous system through release of catecholamines and 
adrenergic receptor stimulation (18, 19). Stress-hormone mediated stimulation of vascular 
beta2-adrenergic receptors releases VWF from endothelial cells (19-21). Stress-induced 
increases in D-dimer and in alpha-receptor activating norepinephrine are correlated with each 
other (5), but beta-adrenergic stimulation did not result in D-dimer increase (20). Compared to 
Caucasians, Africans show a greater alpha-adrenergic vascular response, which is reflected by 
a greater total peripheral resistance (TPR) (22). One specific hypothesis following from the 
above literature is that Africans would show greater D-dimer reactivity but lower VWF 
reactivity to acute stress than Caucasians. More severe depressive symptoms would 
hypothetically relate to greater procoagulant activity in both Africans and Caucasians. 
The primary aim of this study was to investigate procoagulant reactivity between 
Africans and Caucasians through measurements of changes in circulating levels of VWF, 
fibrinogen and D-dimer to acute standardized laboratory stress. A secondary aim was to 
explore the association of depressive symptoms both continuously and categorically (i.e., 
based on a clinical cut-off level, with stress-induced coagulation changes. We further 
examined whether procoagulant reactivity would specifically relate to depressive mood or 
would rather be associated with elevated levels of general psychological distress. 
 
MATERIALS AND METHODS 
Study participants and design 
The participants of this blood coagulation reactivity study were recruited as part of the 
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Sympathetic Activity and Ambulatory Blood Pressure in Africans (SABPA) study conducted 
between February 2008 and May 2009. The study protocol was conducted in accordance with 
the Declaration of Helsinki (23) and was approved by the Ethics Review Board of the North-
West University, Potchefstroom Campus (0003607S6). All participants provided written 
informed consent before participation. The SABPA study has a target population comparative 
design and recruited 409 teachers, aged 25–65 years, working in the Dr Kenneth Kaunda 
Education district in the North West Province, South Africa. This selection assured a 
homogenous sample from a similar socio-economic class. Exclusion criteria included 
pregnancy, lactation, and vaccination or blood donation within 3 months prior to participation. 
For purposes of the present study, we excluded participants with a history of 
atherothrombotic disease (myocardial infarction, n=4; stroke, n=1), atrial fibrillation (n=16), 
and HIV positive status (n=18), all of which are associated with hypercoagulability at rest 
and/or in response to acute stress (10, 24, 25), as well as participants with an ear temperature 
≥37.5°C (n=3) because of a probable acute phase response that might increase coagulation 
factors like fibrinogen. Users of oral anticoagulants (n=2), aspirin (n=12), cortisone (n=3), 
oral contraceptives (n=21), antidepressants (n=3), anxiolytics (n=1), beta blockers (n=4), and 
calcium antagonists (n=12) were also excluded, as all of these might affect resting coagulation 
activity and/or coagulation reactivity with acute mental stress and/or mood (21, 26-29). To 
allow full multivariate statistical analyses, subjects with we also excluded subjects who 
missed data for coagulation measures (n=22), hemodynamic reactivity (n=10), psychological 
questionnaires (n=1), hemoglobin A1c (HbA1c) (n=1), creatinine (n=2), alcohol consumption 
(n=1), and physical activity (n=1). Finally, we excluded 4 participants because of excessively 
high D-dimer levels after stress (≥10’000 ng/ml), yielding a final study sample of 267 
subjects. Excluded participants (n=142) were significantly more often Africans, women, and 
antihypertensive drug users, and they also had significantly higher screening systolic blood 
pressure (SBP), HbA1c, and gamma glutamyl transferase (-GT) levels than those included. 
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The participants were admitted at 4:30 PM to the multi-bedroomed Metabolic Unit 
Research Facility of the North-West University on Monday through Thursday. All received a 
standardized dinner at 06:00 PM after which they completed psychological questionnaires. 
They had their last beverages (tea/coffee) and biscuits at 8:30 PM followed by recreational 
activities such as reading, watching television, or interacting socially. We also obtained 
information on demographic data, general health, including medication, and health behaviors. 
All participants went to bed at around 10:00 PM and were woken at 05:45 AM. After the 
completion of anthropometric and manual BP measurements, a registered nurse obtained 
fasting blood samples which were handled according to standardized procedures. A sterile 
winged infusion set was left in situ with a heparin block (0.5ml of a Heparin Sodium-
Fresenius 5000 IU/ml in 50ml normal saline solution; Fresenius Kabi, Port Elizabeth, South 
Africa) to prevent clotting. Thereafter, all participants underwent the laboratory stress. 
 
Acute laboratory stress testing 
Mental stress test: All participants underwent the Stroop Color-Word Conflict test for 
1 minute. The Stroop is a standardized laboratory stressor showing reproducibility on 
cardiovascular reactivity (30). The Stroop requires identification of the ink color of the word 
rather than the name of the color spelled by the word, under time pressure. The participants 
received a monetary motivation reward in line with performance. Perceived stress triggered 
by the Stroop was rated on a Likert scale (1=”not at all stressful”, 7=”very stressful”). 
Cardiovascular data collection: With participants in a semi-recumbent position a 
registered nurse took a 5-minute continuous measurement of resting cardiovascular 
parameters with the validated Finometer® device (Finapres Medical Systems, Amsterdam, 
the Netherlands) (31). The Finometer provides beat-by-beat BP and thus detects the full 
contour of the cardiovascular responses. The Finometer recorded the SBP, diastolic blood 
pressure (DBP) and heart rate (HR) and computed an integrated age dependent aortic flow 
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curve from the surface area beneath the pressure/volume curve determining cardiac output 
(CO), stroke volume (SV), and total peripheral resistance (TPR) online (32); data were stored 
in the results files. Calculations of SV, CO, and TPR yield reliable measures (33, 34). We 
stabilized BP to resting state before participants underwent the Stroop. We obtained beat-to-
beat BP responses throughout mental stress and the 5 min recovery phase. For analyses, we 
used the average of the last 2 minutes of the resting recordings and the averages of the last 15 
seconds of the stressor recordings as well as of the recovery recordings at 1, 3, and 5 minutes 
after the Stroop had ended. Cardiovascular reactivity was calculated as the area under the 
curve (AUC) with respect to increase from rest (35) across these five time points for SBP, 
DBP, HR, CO, SV, and TPR. 
Blood collection: Citrated blood samples were taken before the Stroop to determine 
resting levels of coagulation measures. At 10 minutes poststress, the infusion set was 
thoroughly flushed with 2-3 ml of saline and the first 2 ml of blood were discarded before 
sampling was done for coagulation measures. Coagulation reactivity was calculated for each 
participant as the percentage change from the resting value.  
 
Cardiometabolic risk factors 
Body mass index: With participants in their underwear, we measured height and 
weight to the nearest 0.1 cm and 0.1 kg to calculate the body mass index (BMI, kg/m2). 
Screening blood pressure: After 5 minutes of rest, using a stethoscope and a mercury 
sphygmomanometer (auscultatory method), duplicate BP readings were taken 5 minutes apart 
and measurements averaged to obtain screening SBP and DBP. 
Blood lipids: Total cholesterol (T-C) and high-density lipoprotein cholesterol (HDL-
C) levels were measured in serum with the Konelab 20i (Thermo Fisher Scientific, Vantaa, 
Finland). For statistical analysis, we computed the T-C/HDL-C ratio. 
Hemoglobin A1c: HbA1c levels were determined by a turbidometric inhibition 
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immunoassay method from EDTA plasma (Integra 400, Roche, Basel, Switzerland). 
Renal function: We used the Modification of Diet in Renal Disease (MDRD) Study 
equation to estimate glomerular filtration rate (eGFR) from creatinine levels, age, sex, and 
ethnicity (36). Creatinine was measured in serum using an enzymatic colorimetric test (Cobas 
Integra 400 plus, Roche, Basel, Switzerland). 
 
Health behaviors 
Smoking: Participants who indicated that they currently smoked and/or had smoked at 
least one cigarette per day during one year in the past were categorized as ever smokers. 
Alcohol consumption: Serum levels of -GT activity were used as a marker of alcohol 
abuse (37) and measured with an enzymatic colorimetric assay (Cobas Integra 400 plus). 
Physical activity: We used the Actical® accelerometers (Montréal, Québec) to 
quantify and index physical activity with 3 (vigorous intensity), 2 (moderate intensity) or 1 
(light intensity) (38). 
 
Coagulation measures 
Blood processing: Citrated blood samples were centrifuged at 1,500 rpm (2000g) for 
15 minutes at room temperature. Citrated plasma samples were aliquoted and frozen at − 
80°C until analysis. Fibrinogen and D-dimer were determined by an accredited laboratory. 
Von Willebrand factor: Plasma VWF:Ag (%) were measured with a "sandwich" 
ELISA assay. A polyclonal rabbit anti-VWF antibody and a rabbit anti -VWF-HRP antibody 
(DAKO, South Africa) were used to form the assay. The 6th International Standard for 
VWF/FVIII was used to set the standard curve against which the samples were measured (39). 
Fibrinogen: Plasma fibrinogen levels (g/l) were determined using a viscosity-based 
method (STA Compact, STAGO Diagnostic, Roche, France). 
D-dimer: Plasma D-dimer levels (ng/ml) were determined with an immuno-based 
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method (STA Compact, STAGO Diagnostic, Roche, France). There were respectively 47.6% 
and 39.7% of D-dimer values at rest and after stress below the limit of detection (<220 
ng/ml). Undetectable values were substituted using the maximum likelihood method that 
generates values from the lognormal distribution of uncensored data under the assumption 
that censored values follow a lognormal distribution. 
 
Psychological questionnaires 
Depressive symptoms: We used the 9-item Patient Health Questionnaire (PHQ-9) to 
measure the frequency of depressive symptoms during the prior two weeks corresponding to 
criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (40). 
Each item is rated on a 4-point scale (0=“not at all“, 1=“several days“, 2= “more than half the 
days”, 3=“nearly every day”) giving a possible global score of 0-27. PHQ-9 scores ≥10 have 
88% sensitivity and specificity for major depression (40). In our sample, Cronbach’s  was 
0.82 for Africans and 0.84 for Caucasians for the total scale. 
Psychological distress: With the 28-item General Health Questionnaire (GHQ-28), we 
quantified perceived psychological distress in general related to symptoms of depression, 
anxiety, somatic complaints and social withdrawal over the past few weeks applying the 
binary scoring method. The global score provides a severity measure of total psychological 
distress. If exceeding the threshold of 4, subjects are classified as achieving „psychiatric 
caseness“ (41). In our sample, Cronbach’s  for the total scale was 0.91 for Africans and 
0.90 for Caucasians. 
 
Statistical analysis 
We used SPSS version 21.0 for Windows to analyze the data with significance level at 
p<0.05 (2-tailed). In case of a non-normal distribution, dependent variables were log 
transformed; for clarity, all data are given in original units. Chi-square test and Student’s t-test 
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with Levene's correction in the case of unequal variances were applied for data comparison 
between groups. We used multivariate analysis of variance (MANOVA) and of covariance 
(MANCOVA) to test for a significant association of ethnicity, PHQ-9 measures, GHQ-28 
measures, and cardiovascular reactivity measures with coagulation measures. We only 
deemed results of individual coagulation measures to be significant if the MAN(C)OVA test 
statistic was significant, as this procedure protects against inflated Type I errors due to 
multiple tests of (likely) correlated dependent variables. Covariates were selected a priori 
based on the literature about demographic, cardiometabolic and life style factors affecting 
circulating levels of coagulation measures (42-44). Effect sizes are expressed as partial eta 
squared (ηp2) or partial correlation coefficients. 
 
RESULTS 
Participant characteristics 
Table 1 shows the demographic and health characteristics of the 267 study participants 
per ethnic group. The percentage of men was higher in Africans than in Caucasians. In terms 
of cardiometabolic risk factors, Africans showed higher BMI, HbA1c, and screening BP – 
despite using more antihypertensives – than Caucasians, while Caucasians had a higher T-
C/HDL-C ratio than Africans. Of the 20 subjects who took antihypertensive medications, 9 
had thiazide diuretics, 6 had angiotensin-converting enzyme (ACE) inhibitors, 2 had 
angiotensin receptor blockers (ARB), and 3 had combination therapy (i.e., thiazide diuretic 
plus ACE inhibitor or ARB). Regarding health behaviors, Africans were physically less active 
and had higher -GT indicating more alcohol abuse than Caucasians. Africans were 
significantly more depressed and they also perceived more distress than Caucasians.  
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Coagulation measures at rest 
Ethnicity: Both MANOVA (F3,263=43.28, ηp2=0.330, p<0.001) and MANCOVA 
(F3,252=36.31, ηp2=0.302, p<0.001) showed a significant association between ethnicity and 
resting levels of the three coagulation measures. Table 2 shows that compared with 
Caucasians, Africans had significantly higher resting levels of VWF, fibrinogen, and D-dimer 
in the unadjusted as well as in the adjusted analyses.  
Psychological questionnaires: To test for an association of PHQ-9 and GHQ-28 
measures with resting levels of coagulation measures, we reran the above MANCOVA with 
continuous and categorical PHQ-9 and GHQ-28 measures as additional covariates (four 
separate models). Ethnicity remained associated with coagulation measures in all of these 
models (all p-values <0.001). However, coagulation measures showed no significant 
association with continuous PHQ-9 scores (p=0.46), categorical PHQ-9 scores (p=0.071), 
continuous GHQ-28 scores (p=0.59), and GHQ-28 caseness (p=0.47).  
Interaction between ethnicity and psychological questionnaires: Taking into account 
main effects of ethnicity and PHQ-9 and GHQ-28 scores, the interaction terms between 
ethnicity and the continuous as well as categorical PHQ-9 and GHQ-28 scores were not 
significant (all p-values >0.10). 
 
Stress-induced changes across all participants 
The mean level of perceived stress from the Stroop was 3.70±1.64 (range 0-7). Mental 
stress provoked significant responses in coagulation and hemodynamic measures. While VWF 
levels increased from 74.9±26.1% to 99.9±40.1% (p<0.001), fibrinogen levels decreased from 
3.18±0.69 g/l to 2.88±0.68 g/l (p<0.001). D-dimer levels showed no significant change 
(320±339 ng/ml vs. 376±503 ng/ml, p=0.44). Moreover, SBP (134.4±16.2 mmHg vs. 
154.2±20.8 mmHg, p<0.001), DBP (78.6±9.3 mmHg vs. 88.6±11.4 mmHg, p<0.001), HR 
(66.8±10.7 bpm vs. 87.4±16.6 bpm, p<0.001), and CO (6.59±1.81 l/min vs. 8.12±2.26 l/min, 
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p<0.001) all increased and SV (99.6±23.9 ml vs. 94.2±23.1 ml, p<0.001) and TPR (1.02±0.46 
mmHg/ml/s vs. 0.99±0.51 mmHg/ml/s, p=0.013) both decreased. 
Association between hemodynamic and coagulation reactivity: Reactivity measures 
of VWF:Ag, fibrinogen, and D-dimer were not significantly correlated with each other (all p-
values >0.25). Separate MANOVA models for AUC measures of hemodynamic variables 
showed that reactivity in DBP (F3,263=3.83, ηp2=0.042, p=0.010), SV (F3,263=3.35, ηp2=0.037, 
p=0.020), and TPR (F3,263=2.74, ηp2=0.030, p=0.044) were significantly associated with 
coagulation reactivity, whereas reactivity in SBP (p=0.44), HR (p=0.83), and CO (p=0.52) 
were not. Correlation analysis on individual measures revealed that VWF reactivity increased 
with greater SV reactivity (r=0.18, p=0.003), but decreased with greater reactivity in DBP 
(r=-0.18, p=0.003) and TPR (r=-0.14, p=0.022). Fibrinogen and D-dimer reactivity were not 
significantly associated with DBP, SV, and TPR reactivity (all p-values >0.12). 
 
Stress-induced changes and ethnicity 
Perceived stress: Africans (3.69 ±1.87) and Caucasians (3.70±1.49) perceived the 
Stroop protocol as similarly stressful (p=0.94). 
Coagulation reactivity: Using MANOVA (p=0.19) and MANCOVA (p=0.62) tests, 
there were no significant associations between ethnicity and poststress levels of coagulation 
measures (cf. Table 2 for unadjusted and adjusted poststress levels of VWF, fibrinogen, and 
D-dimer). However, there were significant association between ethnicity and coagulation 
reactivity in MANOVA (F3,263=13.73, ηp2=0.135, p<0.001) and MANCOVA (F3,251=16.86, 
ηp2=0.168, p<0.001) tests.  Table 1 shows that relative to Caucasians, Africans experienced 
lower procoagulant reactivity with less of an increase in VWF reactivity and more of a 
decrease in fibrinogen reactivity; D-dimer reactivity showed no significant difference between 
Africans and Caucasians. 
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Hemodynamic reactivity: MANCOVA showed a significant association between 
ethnicity and AUC measures of hemodynamic variables (F6,248=3.18, ηp2=0.072, p=0.005). 
Relative to Caucasians, Africans had lower SBP AUC (29.3±5.8 vs. 45.1±4.3, ηp2=0.016, 
p=0.043), and lower SV AUC (–32.3±8.1 vs. 5.4±6.1, ηp2=0.049, p<0.001), but greater TPR 
AUC (0.40±0.27 vs. –0.30±0.20, ηp2=0.029, p=0.007). Ethnicity was not related to AUC 
measures of DBP (p=0.46), HR (p=0.12), and CO (p>0.09). Ethnicity did not significantly 
interact with AUC measures of any cardiovascular parameter to determine coagulation 
reactivity (all p-values >0.18). 
Psychological questionnaires: After controlling for ethnicity MANCOVA tests 
showed no significant associations of continuous PHQ-9 scores (p=0.71), categorical PHQ-9 
scores (p=0.94), continuous GHQ-28 scores (p=0.18), and GHQ-28 caseness (p=0.91) with 
coagulation reactivity. However, there were significant interactions of ethnicity with 
continuous PHQ-9 scores (F3,249=3.03, ηp2=0.035, p=0.030) and categorical continuous PHQ-
9 scores (F3,249=3.80, ηp2=0.044, p=0.011), but not with continuous GHQ-28 scores (p=0.24) 
and GHQ-28 caseness (p=0.62). 
Between-subject analysis revealed significant associations between ethnicity and 
continuous PHQ-9 scores for reactivity of VWF (ηp2=0.016, p=0.044) and fibrinogen 
(ηp2=0.020, p=0.026), but not for D-dimer reactivity (p=0.54). Partial correlation coefficients 
differed significantly between ethnic groups for VWF reactivity (p=0.029) and for fibrinogen 
reactivity (p=0.030). With greater continuously scaled PHQ-9 scores, indicating greater 
severity of depressive symptoms, VWF increased more in Africans (r=0.202) than in 
Caucasians (r=-0.074), whereas fibrinogen decreased more in Africans (r=-0.215) than in 
Caucasians (r=0.058). 
Similarly, ethnicity interacted with categorical PHQ-9 scores in determining VWF 
reactivity (ηp2=0.023, p=0.015) and fibrinogen reactivity (ηp2=0.018, p=0.035), but not D-
dimer reactivity (p=0.28). Figure 1 illustrates these interactions. Partial correlation 
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coefficients significantly differed between groups for VWF reactivity (p=0.035) and for 
fibrinogen reactivity (p=0.047). PHQ-9 scores ≥ 10 were directly correlated with VWF 
reactivity in Africans (r=0.149), but inversely so in Caucasians (r=-0.119). Moreover, PHQ-9 
scores ≥ 10 were inversely correlated with fibrinogen reactivity in Africans (r=-0.187), but 
directly so in Caucasians (r=0.064).  
We performed six complementary univariate analyses of covariance to test whether 
sympathetic activity as indicated by hemodynamic reactivity might relate to the direct 
association between continuous PHQ-9 scores and VWF reactivity in Africans versus 
Caucasians. However, all six three-way-interactions between ethnicity, continuous PHQ-9 
scores and AUC measures of any hemodynamic parameter were non-significant (all p-
values≥0.12). 
 
DISCUSSION 
The main finding from our study is that Africans showed lower procoagulant 
reactivity in response to standardized acute laboratory mental stress when compared with 
Caucasians, controlling for a range of potentially confounding variables. Relative to 
Caucasians, VWF levels had increased less and fibrinogen levels had decreased more in 
Africans after stress relative to resting levels. One explanation for the diminished increase in 
VWF in Africans could be a “ceiling effect” as Africans started out with higher resting levels 
of VWF than Caucasians. For instance, previous studies in apparently healthy individuals 
reported stress-induced increases of VWF of 6%, 9%, and 30% from resting levels which 
were respectively 91%, 98%, and 95%, in these studies (4, 45, 46). This amount of an 
increase in VWF is clearly lower than in our Caucasian subjects who showed an increase in 
VWF of 60% starting out from average resting values of 64%, but similar to our African 
subjects who showed an increase in VWF of 18% from average resting levels of 93%. In 
contrast, a “floor effect” in Caucasians who started out on relatively lower resting fibrinogen 
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levels might account for the greater decrease in poststress fibrinogen levels relative to resting 
levels in Africans. Another explanation for the blunted VWF reactivity in Africans might be 
their alpha-adrenergic vascular stress response, as was suggested by their increased TPR 
reactivity (22). Across all participants, lower VWF reactivity correlated with both greater 
TPR reactivity and lower SV reactivity, the latter likely reflecting increased afterload due to 
elevated TPR (22). Moreover, in Caucasians, the systemic vasodilation response during the 
Stroop test is largely mediated by the beta2-adrenergic receptor (47) whose stimulation 
through stress hormones will result in endothelial release of VWF into the circulation (19-21).  
A decrease in fibrinogen levels between rest and 10 minutes after the Stroop was seen 
across all study participants, and to an even greater extent in Africans than Caucasians. This is 
contrary to expectations, as fibrinogen levels were shown to increase in response to acute 
mental stress in several previous studies (2-4). The Stroop protocol provoked an average level 
of psychological distress that compares to similar protocols (10). However, previous studies 
suggest that the Stroop alone might be less effective in provoking a significant fibrinogen 
response (48) than combinations of the Stroop with other stressors (e.g., mental arithmetic) 
(45) or speech stressors (4). As there was no correlation of VWF reactivity with both 
fibrinogen and D-dimer reactivity in the present study, but in a previous one (49), it is also 
possible that the 1-minute stressor was too short to evoke a significant fibrinogen increase 
with fibrin formation and degradation further downstream. Nevertheless, previous studies 
showed coagulation and fibrinolysis activation within 2 to 5 minutes of acute mental stress 
(50, 51) and infusion with the stress hormone epinephrine (52). D-dimer did not increase in a 
previous study that combined the Stroop with mental arithmetic (53), but in studies that 
applied speech stressors to inflict social evaluative threat (5, 9). The sensitivity of the various 
D-dimer assays used in previous stress studies might also explain heterogeneous results (54). 
Saying that, previous stress reactivity studies also used different methods to measure 
fibrinogen (e.g., the functional Clauss method) (4) and VWF (e.g., enzyme-linked 
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immunosorbent assays) (46). To our knowledge, a direct comparison of the sensitivity 
between different assays to detect reactivity in prothrombotic measures has not been 
performed, but would seem important to reconcile heterogeneous study findings.  
Coagulation reactivity was specifically associated with depressive symptoms (i.e., 
PHQ-9 scores) as opposed to more general psychological distress (i.e., GHQ-28 scores). More 
severe depressive symptoms were associated with greater VWF reactivity in Africans 
compared with Caucasians. This concurs with the notion that depressive mood along a 
continuum of severity is associated with an increased risk of incident CVD and recurrent 
cardiac events (55). However, poststress levels of VWF and fibrinogen were similar in 
Africans and Caucasians, fibrinogen decreased more in depressed Africans than depressed 
Caucasians, and VWF reactivity was, on the whole, lower in Africans than in Caucasians; 
therefore, a depression-associated increase in CVD risk in Africans through a pathway of 
stress-induced VWF increase would need to be shown in prospective studies. 
Ethnical differences in coagulation are still poorly understood with studies showing 
enhanced clotting but also increased bleeding tendency in various clinical settings in Africans 
compared with Caucasians (56). We found resting levels of VWF:Ag, fibrinogen, and D-
dimer to be higher in Africans than Caucasians, which is in agreement with some previous 
studies (57-59). Theoretically, this potential predisposition to hypercoagulability might 
contribute to the CVD risk in Africans. In contrast, lower increase in VWF levels and greater 
decrease in fibrinogen levels both with acute mental stress could be viewed a hypoactive 
fight-flight response (60). As opposed to constitutively released VWF, the VWF released 
from the endothelium after stimulation consists of large and hemostatically highly active 
multimers (61). Moreover, although not investigated in our study, acute stress also activates 
fibrinolysis (2, 45, 50). Therefore, the inability to mount physiologic hypercoagulability might 
subject Africans to an increased risk of bleeding in fight-flight situations either upon injury or 
even spontaneously. Therefore, the almost absent VWF response in the non-depressed 
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Africans might be as harmful as the increased VWF reactivity in the depressed Africans for 
the maintenance of the haemostatic balance between thrombosis and haemorrhage during 
acute mental stress. 
Rigorous selection of participants on medical characteristics to minimize confounding 
of coagulation measures was a strength of our study, but also might reduce generalizability of 
study findings to the larger African population and those with established CVD. We selected 
three coagulation measures that were previously shown to be stress-responsive. However, 
they do not cover the entire dynamics of the coagulation and fibrinolysis pathways during 
acute mental stress. A speech stressor inflicting social evaluative threat and measuring 
coagulation measures longer into the recovery period from stress might have provided 
additional informative data. The Stroop test provoked substantial increases in BP and HR, but 
there is an ongoing debate as to whether cardiovascular reactivity data gained from 
standardized lab stressor are generalizable to real life situations (62). We controlled our 
analysis for antihypertensive medications as a group but due to insufficient statistical power 
could not take into account potential class effects of the different antihypertensives on 
outcomes. We did not include a non-stress control group. Therefore we were unable to 
account for circadian changes in coagulation measures, particularly so a decrease in plasma 
fibrinogen levels during the morning hours. We are unable to account for the possibility that 
stress-related changes in clearance impacted plasma concentrations of coagulation measures. 
For instance, glycosylation of VWF influences its clearance by the liver, which, moreover, 
occurs more rapidly in individuals with blood group O than in non-O individuals (63); 
unfortunately, information on ABO blood group was not available in our study. The 
difference in liver function between Africans and Caucasians seems not an apparent 
explanation for the ethnic difference in VWF reactivity because the relation between ethnicity 
and procoagulant reactivity persisted after adjustment for -GT activity. 
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Taken together, Africans seem to have lower procoagulant reactivity with acute 
mental stress than Caucasians. This observation might partially be explained by ethnic 
differences in the vascular stress response. Depressive symptoms may modulate coagulation 
reactivity against an ethnic background. The potential clinical implications of our findings for 
CVD risk and bleeding disorders in Africans need further studies. 
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Legend to Figure 1 
The figure depicts the multivariate-adjusted interaction effects between ethnicity and 
categorical depression (i.e., score ≥10 on the PSQ-9 total depressive symptom scale) on von 
Willebrand factor (VWF) and fibrinogen reactivity (i.e., relative change in levels of 
coagulation measures in % from resting levels to 10 minutes after the Stroop test). Relative to 
non-depressed individuals (Dep –) of the respective ethnicity, VWF reactivity was 
significantly greater in Africans vs. Caucasians with depression (Dep +). Fibrinogen reactivity 
showed a significantly greater decrease in depressed Africans than in depressed Caucasians 
(cf. text for detailed statistics). Africans/Dep + (n=47), Africans/Dep – (n=55), 
Caucasians/Dep + (n=29), Caucasians/Dep – (n=136). 
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Table 1. Characteristics of 267 study participants 
Variable Africans 
(n=102) 
Caucasians 
(n=165) 
P-value 
Gender (% men) 62.7 49.7 0.037 
Age (yrs) 43.4±8.2 44.1±11.0 0.580 
Body mass index (kg/m2) 29.9±7.8 27.6±5.6 0.008 
Total cholesterol (mmol/l) 4.76±1.17 5.50±1.22 <0.001 
HDL-cholesterol (mmol/l) 1.15±0.36 1.20±0.41 0.339 
Total cholesterol/HDL-cholesterol ratio 4.51±1.86 4.98±1.60 0.028 
Systolic blood pressure (mmHg) 134.4±19.6 126.7±13.5 <0.001 
Diastolic blood pressure (mmHg) 88.4±12.6 83.1±9.6 <0.001 
Hemoglobin A1c (%) 6.05±1.12 5.48±0.41 <0.001 
Creatinine (µmol/l) 77.6±13.5 74.2±15.3 0.069 
Estimated GFR (ml/min/1.73m2) 114.7±29.3 112.0±27.2 0.453 
Ever smoker (%) 25.5 21.2 0.419 
Gamma glutamyl transferase (U/L) 64.6±75.8 26.9±36.2 <0.001 
Physical activity index 1.33±0.57 1.62±0.70 0.001 
Antihypertensive drugs (%) 12.7 4.2 0.010 
Patient Health Questionnaire-9 (scores)    
    Total depressive symptoms 9.40±5.60 5.70±4.73 <0.001 
    Moderate depression (cut-off ≥10) (%) 46.1 17.6 <0.001 
General Health Questionnaire-28 (scores)    
    Total psychological distress 8.50±6.71 3.79±4.80 <0.001 
    Cases (cut-off >4) (%) 64.7 33.3 <0.001 
 
Data are given as means±SD or percentage values. P-value refers to group differences.  
GFR, glomerular filtration rate; HDL, high-density lipoprotein 
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Table 2. Coagulation measurements per ethnic group at rest and after mental stress 
Condition Adj. von Willebrand factor Fibrinogen D-dimer 
 + Africans Caucasians ES P Africans Caucasians ES P Africans Caucasians ES P 
Rest – 93.2± 28.4% 63.6±16.5% 0.330 <0.001 3.35±0.82g/l 3.07±0.57g/l 0.030 0.004 354±340ng/ml 298±338ng/ml 0.015 0.044 
 + 94.2±2.4% 62.9±1.8% 0.291 <0.001 3.33±0.06g/l 3.09±0.05g/l 0.029 0.006 379±37ng/ml 283±28ng/ml 0.030 0.005 
Poststress – 101.8±34.1% 98.7±43.4% 0.010 0.101 2.95±0.71g/l 2.84±0.65g/l 0.006 0.208 398±515ng/ml 363±496ng/ml 0.004 0.302 
 + 97.5±4.4% 101.4±3.3% <0.001 0.817 2.91±0.07g/l 2.86±0.05g/l 0.001 0.593 426±56ng/ml 345±42ng/ml 0.006 0.217 
Reactivity – 18.1±53.6% 60.1±70.2% 0.110 <0.001 –11.2±11.6% –7.4±12.6% 0.022 0.016 64.5±241.9% 74.5±319.9% 0.002 0.499 
 + 10.2±7.0% 65.0±5.2% 0.140 <0.001 –11.7±1.4% –7.2±1.0% 0.023 0.016 48.1±32.6% 84.7±24.6% 0.005 0.270 
 
Data are given as means±SD for unadjusted values (–) and as means±SEM for adjusted values (+) with P-values for group comparisons. 
Adjustment was made for gender, age, body mass index, total cholesterol/high-density cholesterol ratio, screening systolic blood pressure, hemoglobin A1c, estimated glomerular 
filtration rate, smoking, gamma glutamyl transferase, physical activity, and antihypertensive drugs for resting values and additionally for perceived stress with the Stroop test for 
post-stress and reactivity values. Reactivity measures are expressed as percentage change of posttstress values from resting values. 
Adj., adjustment; ES, effect sizes (partial eta-squared). 
 
 
 
 29 
Extra Table 
What is known about this topic? 
 Acute mental stress induces a hypercoagulable state that may contribute to 
atherothrombotic diseases. 
 Depressive symptoms are associated with the procoagulant stress response. 
 There are ethnic differences in coagulation between Africans and Caucasians. 
What this paper adds 
 Africans show lower procoagulant reactivity in response to acute laboratory mental stress 
than Caucasians 
 Explanation might be higher resting levels of coagulation factors in Africans than 
Caucasians and ethnic differences in the vascular stress response. 
 Depressive symptoms are associated with greater stress reactivity of von Willebrand 
factor in Africans relative to Caucasians. 
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Figure 1: Coagulation reactivity related to ethnicity and depression 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
